Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Notes underwriting agrmnt Inv. presentation Quarterly results Acq. announced
|
Vistagen Therapeutics, Inc. (VTGN)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/28/2023 |
10-K
| Annual Report for the period ended March 31, 2023 |
06/23/2022 |
10-K
| Annual Report for the period ended March 31, 2022 |
06/29/2021 |
10-K
| Annual Report for the period ended March 31, 2021 |
06/29/2020 |
10-K
| Annual Report for the period ended March 31, 2020 |
06/25/2019 |
10-K
| Annual Report for the period ended March 31, 2019 |
06/26/2018 |
10-K
| Annual Report for the period ended March 31, 2018 |
06/28/2017 |
10-K
| Annual Report for the period ended March 31, 2017 |
06/24/2016 |
10-K
| Annual Report for the period ended March 31, 2016 |
06/29/2015 |
10-K
| Annual Report for the period ended March 31, 2015 |
06/25/2014 |
10-K
| Annual Report for the period ended March 31, 2014 |
07/18/2013 |
10-K
| Annual Report for the period ended March 31, 2013 |
07/02/2012 |
10-K
| Annual Report for the period ended March 31, 2012 |
03/31/2011 |
10-K
| Annual Report for the period ended December 31, 2010 |
08/04/2010 |
10-K/A
| Annual Report for the period ended December 31, 2009 [amend] |
03/17/2010 |
10-K
| Annual Report for the period ended December 31, 2009 |
03/31/2009 |
10-K
| Annual Report for the period ended December 31, 2008 |
|
|